← Open Payments lookup

DAWN O'KEEFE: Open Payments

NPI 1477022135 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,298 in 43 payments from 10 companies in 2025. Trend: 2023 $100 · 2024 $717 · 2025 $2,298

Food & beverage: $2,082Education: $216
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.8$547
Teva Pharmaceuticals USA, Inc.6$417
Alkermes, Inc.6$403
Otsuka America Pharmaceutical, Inc.12$299
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$288
Supernus Pharmaceuticals, Inc.1$115
E.R. Squibb & Sons, L.L.C.2$83
Dynavax Technologies Corporation1$75
Otsuka Pharmaceutical Development & Commercialization, Inc.1$44
Braeburn Inc.1$26

Products named: INGREZZA, CAPLYTA, ABILIFY ASIMTUFII, ARISTADA, Qelbree, LYBALVI, VIVITROL, UZEDY.

Industry payments across CO — which companies pay providers there.